Your browser doesn't support javascript.
loading
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Zimmerli, Dario; Brambillasca, Chiara S; Talens, Francien; Bhin, Jinhyuk; Linstra, Renske; Romanens, Lou; Bhattacharya, Arkajyoti; Joosten, Stacey E P; Da Silva, Ana Moises; Padrao, Nuno; Wellenstein, Max D; Kersten, Kelly; de Boo, Mart; Roorda, Maurits; Henneman, Linda; de Bruijn, Roebi; Annunziato, Stefano; van der Burg, Eline; Drenth, Anne Paulien; Lutz, Catrin; Endres, Theresa; van de Ven, Marieke; Eilers, Martin; Wessels, Lodewyk; de Visser, Karin E; Zwart, Wilbert; Fehrmann, Rudolf S N; van Vugt, Marcel A T M; Jonkers, Jos.
Afiliación
  • Zimmerli D; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Brambillasca CS; Oncode Institute, Utrecht, The Netherlands.
  • Talens F; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bhin J; Oncode Institute, Utrecht, The Netherlands.
  • Linstra R; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Romanens L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bhattacharya A; Oncode Institute, Utrecht, The Netherlands.
  • Joosten SEP; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Da Silva AM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Padrao N; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wellenstein MD; Translational Research Centre in Oncohaematology, University of Geneva, Geneva, Switzerland.
  • Kersten K; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • de Boo M; Oncode Institute, Utrecht, The Netherlands.
  • Roorda M; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Henneman L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Bruijn R; Oncode Institute, Utrecht, The Netherlands.
  • Annunziato S; Oncode Institute, Utrecht, The Netherlands.
  • van der Burg E; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Drenth AP; Oncode Institute, Utrecht, The Netherlands.
  • Lutz C; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Endres T; Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, Utrecht, The Netherlands.
  • van de Ven M; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Eilers M; Department of Pathology, University of California, San Francisco, CA, USA.
  • Wessels L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Visser KE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Zwart W; Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Fehrmann RSN; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Vugt MATM; Oncode Institute, Utrecht, The Netherlands.
  • Jonkers J; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nat Commun ; 13(1): 6579, 2022 11 02.
Article en En | MEDLINE | ID: mdl-36323660
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article